Illumina
-
Opportunity India Desk May 24 2022 - 3 min readGenes2Me has launched wide range of Next-Generation Sequencing (NGS)-based panels for oncology, personalised medicine, and hereditary diseases. According to the press note, by selectively targeting the clinically significant genes, these NGS panels enable comprehensive analysis with the most effective sequencing throughput. These panels have been designed and validated for all the common NGS platforms from ...